On Tuesday, Olema Pharmaceuticals Inc (NASDAQ: OLMA) opened lower -4.30% from the last session, before settling in for the closing price of $4.19. Price fluctuations for OLMA have ranged from $2.86 to $16.62 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 12.18% at the time writing. With a float of $52.12 million, this company’s outstanding shares have now reached $68.33 million.
The firm has a total of 96 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Olema Pharmaceuticals Inc (OLMA) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Olema Pharmaceuticals Inc is 23.83%, while institutional ownership is 79.44%. The most recent insider transaction that took place on Jan 08 ’25, was worth 1,727,370. In this transaction 10% Owner of this company bought 300,000 shares at a rate of $5.76, taking the stock ownership to the 7,800,000 shares. Before that another transaction happened on Dec 17 ’24, when Company’s Director sold 700,761 for $6.75, making the entire transaction worth $4,730,137. This insider now owns 0 shares in total.
Olema Pharmaceuticals Inc (OLMA) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.18% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.25% during the next five years compared to -83.00% drop over the previous five years of trading.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Check out the current performance indicators for Olema Pharmaceuticals Inc (OLMA). In the past quarter, the stock posted a quick ratio of 15.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.95, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -2.18 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Analysing the last 5-days average volume posted by the [Olema Pharmaceuticals Inc, OLMA], we can find that recorded value of 0.84 million was lower than the volume posted last year of 0.98 million. As of the previous 9 days, the stock’s Stochastic %D was 33.32%. Additionally, its Average True Range was 0.37.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 29.93%, which indicates a significant increase from 6.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 97.27% in the past 14 days, which was higher than the 76.12% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.56, while its 200-day Moving Average is $7.26. Now, the first resistance to watch is $4.20. This is followed by the second major resistance level at $4.40. The third major resistance level sits at $4.50. If the price goes on to break the first support level at $3.90, it is likely to go to the next support level at $3.80. Should the price break the second support level, the third support level stands at $3.60.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
There are currently 68,421K shares outstanding in the company with a market cap of 274.37 million. Presently, the company’s annual sales total 0 K according to its annual income of -129,470 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -30,390 K.
